You are here: Industry Insights > vaccine

News List

The global smart syringe market should surpass $15,500mn by 2027, finds report europeanpharmaceuticalreview
February 24, 2021
The smart syringe market should grow due to increasing public awareness surrounding vaccination and the increasing popularity of safety injection devices with manufacturers and healthcare professionals.
FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants americanpharmaceuticalreview
February 23, 2021
The U.S. Food and Drug Administration (FDA) has issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2 ...
Vaccination offers consistent long term protection: Experts expresspharma
February 23, 2021
Vaccination offers much stronger immune response than natural infection, and therefore is the key to controlling the spread of the disease.
How is a vaccine engineered? expresspharma
January 26, 2021
Vaccines are among the most effective means of preventing infectious diseases. Vaccines train our immune system to mount a defence against pathogens by creating antibodies.
Clinical microbiology to play key role in COVID-19 response, report says europeanpharmaceuticalreview
January 22, 2021
New research has said that clinical microbiology is critical to understanding COVID-19, with laboratories studying the coronavirus globally.
UK vaccine supply chain workers to be offered COVID-19 jabs europeanpharmaceuticalreview
January 21, 2021
Around 2,000 workers critical to the UK COVID-19 vaccine supply chain will be offered inoculations against the novel coronavirus.
South Africa to get nine million doses of J&J vaccine: Business Day expresspharma
January 19, 2021
South Africa, which has yet to receive its first coronavirus vaccine, has been promised nine million doses by Johnson & Johnson, the Business Day newspaper reported, citing a health ministry spokeswoman.
Dr Reddy’s gets DCGI nod for Phase 3 clinical trial for Sputnik V vaccine expresspharma
January 18, 2021
The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Anvisa sends back request for EUA of Sputnik V vaccine expresspharma
January 18, 2021
Anvisa said that Uniao Quimica, the pharma firm applying for EUA of Sputnik V vaccine, failed to provide adequate assurances on its Phase III clinical trials and issues related to the manufacture of the vaccine.
SII expects WHO emergency nod for AstraZeneca – Oxford University vaccine soon expresspharma
January 15, 2021
Poonawalla also said his company would start stockpiling millions of doses of the Novavax coronavirus vaccine candidate from around April.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page